BioArctic AB (publ) (BRCTF)
Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Dr. Gunilla Osswald Ph.D. | President & CEO | 8.1M | -- | 1961 |
| Dr. Pär Gellerfors | Co-Founder, Senior VP of Business Strategy & Director | 387k | -- | 1947 |
| Prof. Lars Lannfelt | Co-Founder, Senior VP of Medical science & Director | 2.37M | -- | 1949 |
| Mr. Anders Martin-Lof M.B.A., M.Sc. | Chief Financial Officer | -- | -- | 1971 |
| Ms. Johanna Fälting | Chief R&D Officer and Head of Research & Development | -- | -- | 1972 |
| Mr. Christer Möller | VP of Pre-Clinical Development & Chief Scientific Officer | -- | -- | 1959 |
| Mr. Oskar Bosson | VP and Head of IR & Communication | -- | -- | 1976 |
| Mr. Leif Gallo LL.M. | General Counsel and Head of Legal & IP | -- | -- | 1959 |
| Mr. Harald Borgeke | Head of Public Affairs | -- | -- | -- |
| Ms. Frida Lekander | Head of Marketing | -- | -- | -- |
BioArctic AB (publ)
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 116
Description
BioArctic AB (publ) develops biological drugs for patients with central nervous system disorders in Sweden. It engages in the research and development of innovative biological drugs, such as antibodies that address high unmet medical needs. The company's therapeutic areas encompass neurodegenerative disorders, such as Alzheimer's disease, Parkinson's disease, and other CNS diseases. In addition, it owns a technology platform, which develops a range of therapeutic monoclonal antibodies. Additionally, the company is developing lecanemab, which is in phase 3 clinical trials; Lecanemab that is in back-up phase 3 clinical trials; Exidavnemab, which is in phase 2 clinical trials; Lecanemab, BAN2803, and BAN2802 that are in preclinical trials; and BAN1503, PD-BT2238, ND-BT3814, and GD-BT6822, which are in discovery stage. It has research collaboration agreements with Eisai and AbbVie. The company was formerly known as BioArctic Neuroscience AB and changed its name to BioArctic AB (publ) in 2016. BioArctic AB (publ) was incorporated in 2000 and is based in Stockholm, Sweden.
Corporate Governance
Upcoming Events
August 28, 2025 at 6:00 AM UTC
BioArctic AB (publ) Earnings Date
Recent Events
Recent Events Information Not Available